PROMIS NEUROSCIENCES INC. Share Price
PROMIS NEUROSCIENCES INC. (PMN) had Share Price of 1.3 CAD/shares as of 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:SharePrice · last filed 2024-04-01
- 2023-12-31: Share Price 1.30 CAD/shares.
- 2023-07-01: Share Price 2.54 CAD/shares.
- 2022-12-31: Share Price 5.84 CAD/shares.
- 2022-09-30: Share Price 5.84 CAD/shares.
CAD/shares
| Period end | Share Price |
|---|---|
| 2023-12-31 | 1.30 CAD/shares 10-K · filed 2024-04-01 |
| 2023-07-01 | 2.54 CAD/shares 10-K · filed 2024-04-01 |
| 2022-12-31 | 5.84 CAD/shares 10-K · filed 2023-03-08 |
| 2022-09-30 | 5.84 CAD/shares 10-Q · filed 2022-11-14 |
| 2022-06-30 | 6.35 CAD/shares 10-Q · filed 2022-08-12 |
| 2021-12-31 | 6.00 CAD/shares 10-K · filed 2023-03-08 |
| 2021-09-30 | 6.24 CAD/shares 10-Q · filed 2022-11-14 |
| 2021-06-30 | 14.40 CAD/shares 10-Q · filed 2022-08-12 |
USD/shares
| Period end | Share Price |
|---|---|
| 2023-12-31 | $1.53 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |